Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor plus aspirin for secondary prevention after prior myocardial infarction
2009-017242-30Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) and atherothrombosis comparing Ticagrelor + aspirin with Placebo + aspirin (2 arms). Primary endpoint: Composite major cardiovascular event endpoint. Started Oct 2010; status: completed.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)atherothrombosis
Beyond the preview
Go deeper on 2009-017242-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017242-30.